Lixte Biotechnology Holdings, Inc. Warrants Insider Trading Activity
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Insider Trade Summary
Grant/Award: 17,754 shares
Grant/Award
2 txns
Insider
Forman Stephen J.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Options to Purchase Common Stock | 10,000 | $0.00 | $0.00 |
| Grant/Award | Options to Purchase Common Stock | 7,754 | $0.00 | $0.00 |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Warrants to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Options to Purchase Common Stock | -- | -- | -- |
| Holding | Warrants to Purchase Common Stock | -- | -- | -- |
Holdings After Transaction:
Options to Purchase Common Stock — 80,177 options, with 62,423 underlying shares of Common (Direct);
Warrants to Purchase Common Stock — 3,772 warrants (Indirect, By Stephen Forman Living Trust)
Holdings Before and After:
Options to Purchase Common Stock, 62,423 to 80,177 options (Direct)
Footnotes (2)
- F1. Effective June 30, 2025, the reporting person was granted stock options to purchase an aggregate of 10,000 shares vesting in eight equal installments on the last day of each subsequent quarter until fully vested with vesting to start on September 30, 2025.
- F2. Effective June 30, 2025 the reporting person was granted stock options in aggregate of 7,754 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
